Decoy Therapeutics
DCOY · NASDAQ
$1.14−$0.035 (−2.99%)TodayMarket closed ·
Prev close $1.17
Who owns DCOY
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 27.7% of DCOY’s shares.
- Armistice Capital LLC12.4%
- Heights Capital Management, Inc.11.1%
- Hibner (Barbara Louise Ph.D.)0.8%
- Vanguard Capital Management, LLC0.8%
- Next 6 largest institutions2.6%
- All other shareholders72.3%
| Holder | Shares | % of shares |
|---|---|---|
| Armistice Capital LLC | 65.50K | 12.36% |
| Heights Capital Management, Inc. | 59.05K | 11.14% |
| Hibner (Barbara Louise Ph.D.) | 4.22K | 0.80% |
| Vanguard Capital Management, LLC | 4.03K | 0.76% |
| Marschel (Peter Klaus) | 3.90K | 0.74% |
| McVicar (William Kenneth) | 3.00K | 0.57% |
| Burleson (Tess) | 2.00K | 0.38% |
| Gauthier (Patricia G.) | 2.00K | 0.38% |
| Rosenblum (Mark J) | 1.68K | 0.32% |
| Pierce (Frederick E) | 1.39K | 0.26% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Extended Market Index Fund | 4.03K | 0.76% |
| Fidelity Extended Market Index Fund | 2.90K | 0.55% |
| Fidelity Series Total Market Index Fund | 477 | 0.09% |
| Horizon Kinetics Medical ETF | 21 | 0.00% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of DCOY in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Gauthier Patricia G. | Award | 2.00K | — |
| Marschel Peter Klaus | Award | 3.90K | — |
| Hibner Barbara Louise | Award | 4.22K | — |
| Burleson Tess | Award | 2.00K | — |
| McVicar William K. | Award | 3.00K | — |
| Lammers Paul | Award | 2.00K | — |
| Lieber Jonathan I | Award | 2.00K | — |
| Rosenblum Mark J | Award | 9.68K | — |
| HANISH ARNOLD C | Award | 3.00K | — |
| PIERCE FREDERICK II | Award | 33.45K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 150.34K
- Days to cover
- 1.00
- % of shares outstanding
- 28.37%
- Average daily volume
- 11.99M
- Change since last report
- +1321.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.